Skip to content
10-Q

Quarterly Report

PURE Bioscience, Inc. PURE

0001493152-26-010385

← back to feed
Filed
Mar 17, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Mar 16, 2026 111.89M sh
Shares Diluted Q2 2026 · Jan 31, 2026 111.89M sh
Shares Diluted Q2 2026 · Jan 31, 2026 111.89M sh
Shares Diluted Q2 2026 · Jan 31, 2025 111.86M sh
Shares Diluted Q2 2026 · Jan 31, 2025 111.86M sh
Operating Cash Flow Q2 2026 · Jan 31, 2026 −$856K
Operating Cash Flow Q2 2026 · Jan 31, 2025 −$1.05M
Cash And Equivalents Q2 2026 · Jan 31, 2026 $198K
Cash And Equivalents Q2 2026 · Jul 31, 2025 $334K
Cash And Equivalents Q2 2026 · Jan 31, 2025 $202K
Stockholders Equity Q2 2026 · Jan 31, 2026 −$6.27M
Stockholders Equity Q2 2026 · Oct 31, 2025 −$5.55M
Stockholders Equity Q2 2026 · Jul 31, 2025 −$5.12M
Stockholders Equity Q2 2026 · Jan 31, 2025 −$4.27M
Stockholders Equity Q2 2026 · Oct 31, 2024 −$3.5M
Stockholders Equity Q2 2026 · Jul 31, 2024 −$2.86M
Current Liabilities Q2 2026 · Jan 31, 2026 $3.06M
Current Liabilities Q2 2026 · Jul 31, 2025 $938K
Total Liabilities Q2 2026 · Jan 31, 2026 $7.06M
Total Liabilities Q2 2026 · Jul 31, 2025 $6.17M
Current Assets Q2 2026 · Jan 31, 2026 $779K
Current Assets Q2 2026 · Jul 31, 2025 $1.05M
Total Assets Q2 2026 · Jan 31, 2026 $788K
Total Assets Q2 2026 · Jul 31, 2025 $1.06M
Eps Diluted Q2 2026 · Jan 31, 2026 −$0.01
Eps Diluted Q2 2026 · Jan 31, 2026 −$0.01
Eps Diluted Q2 2026 · Jan 31, 2025 −$0.01
Eps Diluted Q2 2026 · Jan 31, 2025 −$0.01
Eps Basic Q2 2026 · Jan 31, 2026 −$0.01
Eps Basic Q2 2026 · Jan 31, 2026 −$0.01
Eps Basic Q2 2026 · Jan 31, 2025 −$0.01
Eps Basic Q2 2026 · Jan 31, 2025 −$0.01
Sga Expense Q2 2026 · Jan 31, 2026 $847K
Sga Expense Q2 2026 · Jan 31, 2026 $1.59M
Sga Expense Q2 2026 · Jan 31, 2025 $871K
Sga Expense Q2 2026 · Jan 31, 2025 $1.75M
Rd Expense Q2 2026 · Jan 31, 2026 $74K
Rd Expense Q2 2026 · Jan 31, 2026 $160K
Rd Expense Q2 2026 · Jan 31, 2025 $81K
Rd Expense Q2 2026 · Jan 31, 2025 $152K
Net Income Q2 2026 · Jan 31, 2026 −$785K
Net Income Q2 2026 · Jan 31, 2026 −$1.25M
Net Income Q2 2026 · Jan 31, 2025 −$798K
Net Income Q2 2026 · Jan 31, 2025 −$1.49M
Operating Income Q2 2026 · Jan 31, 2026 −$683K
Operating Income Q2 2026 · Jan 31, 2026 −$1.06M
Operating Income Q2 2026 · Jan 31, 2025 −$725K
Operating Income Q2 2026 · Jan 31, 2025 −$1.35M
Gross Profit Q2 2026 · Jan 31, 2026 $238K
Gross Profit Q2 2026 · Jan 31, 2026 $688K
Gross Profit Q2 2026 · Jan 31, 2025 $227K
Gross Profit Q2 2026 · Jan 31, 2025 $552K
Cost Of Revenue Q2 2026 · Jan 31, 2026 $206K
Cost Of Revenue Q2 2026 · Jan 31, 2026 $464K
Cost Of Revenue Q2 2026 · Jan 31, 2025 $164K
Cost Of Revenue Q2 2026 · Jan 31, 2025 $395K
Revenue Q2 2026 · Jan 31, 2026 $444K
Revenue Q2 2026 · Jan 31, 2026 $1.15M
Revenue Q2 2026 · Jan 31, 2025 $391K
Revenue Q2 2026 · Jan 31, 2025 $947K